Patents Assigned to Selena Pharmaceuticals, Inc.
  • Agent for treating neurodegenerative disorders
    Patent number: 6187785
    Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein R1 is Me, Et or PhCH2; R2 is H, PhCH2 or 6-Me-3-Py—(CH2)2; and R3 is H, Me or Br. The solid line accompanied by the dotted line, i.e. — represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: February 13, 2001
    Assignee: Selena Pharmaceuticals, Inc.
    Inventors: Nikolai S. Zefirov, Andrei Z. Afanasiev, Svetlana V. Afanasieva, Sergei O. Bachurin, Sergei E. Tkachenko, Vladimir V. Grigoriev, Marina A. Jurovskaya, Valery P. Chetverikov, Elizaveta E. Bukatina, Irina V. Grigorieva